Mount Med Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
- Paid Up Capital ₹ 0.20 M
- Company Age 9 Year, 9 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.13 M
- Revenue Growth 35.25%
- Profit Growth 165.63%
- Ebitda 68.02%
- Net Worth 46.78%
- Total Assets 23.92%
About Mount Med Life Sciences
Mount Med Life Sciences Private Limited (MMLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 February 2016 (Nine years 9 days old ). Its registered office is in North West Delhi, Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.20 M.
The company currently has active open charges totaling ₹2.13 M.
Prabhat Mehta and Benu Mehta serve as directors at the Company.
Company Details
- Location
North West Delhi, Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51101DL2016PTC291318
- Company No.
291318
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Feb 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Mount Med Life Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prabhat Mehta  | Director | 17-Feb-2016 | Current |
| Benu Mehta | Director | 27-Apr-2018 | Current |
Financial Performance of Mount Med Life Sciences.
Mount Med Life Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 35.25% increase. The company also saw a substantial improvement in profitability, with a 165.63% increase in profit. The company's net worth Soared by an impressive increase of 46.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mount Med Life Sciences?
Unlock access to Mount Med Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹2.13 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.21 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Mar 2023 | Hdfc Bank Limited | ₹1.03 M | Open |
| 28 Oct 2021 | Hdfc Bank Limited | ₹1.11 M | Open |
How Many Employees Work at Mount Med Life Sciences?
Mount Med Life Sciences has a workforce of 28 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mount Med Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mount Med Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
